Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03924752 · ClinicalTrials.gov registry record · NA

Powered Hip Exoskeleton Assistance Study

A NA study of Lower Limb Injury, sponsored by Georgia Institute of Technology.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03924752 is a NA study of Lower Limb Injury that has completed, run by Georgia Institute of Technology. The registered enrollment target is 10 participants, below the 52-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03924752, a NA study of Lower Limb Injury, has completed, sponsored by Georgia Institute of Technology.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals who have walking impairments due to disease to increase their community mobility, independence, and health. Robotic exoskeletons have the potential to assist these individuals by increasing community mobility to improve quality of life. While these devices have incredible potential, current technology does not support dynamic movements common with locomotion such as transitioning between different gaits and supporting a wide variety of walking speeds. One significant challenge in achieving community ambulation with exoskeletons is providing an adaptive control system to accomplish a wide variety of locomotor tasks. Many exoskeletons today are developed without a detailed understanding of the effect of the device on the human musculoskeletal system. This research is interested in studying the question of how the control system affects human biomechanics including kinematic, kinetics and muscle activation patterns. By optimizing exoskeleton controllers based on human biomechanics and adapting control based on task, the biggest benefit to patient populations will be achieved to help advance the state-of-the-art with assistive hip exoskeletons.

Conditions Studied

Interventions

  • DEVICE Powered hip exoskeleton

Study Locations (1)

Georgia

  • Exoskeleton and Prosthetic Intelligent Controls Lab - Atlanta

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-02-13
Est. Completion 2021-03-15
Phase NA

Sponsor

Georgia Institute of Technology

24 total trials

What the Registry Record Tells You About NCT03924752

The ClinicalTrials.gov registry entry for NCT03924752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (81% lower). The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lower Limb Injury appearing as the primary indexed condition, and to 1 intervention - of which Powered hip exoskeleton is the first listed.

NCT03924752 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03924752 about?

NCT03924752 is a clinical study titled "Powered Hip Exoskeleton Assistance Study". The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals who have walking impairments due to disease to increase their c...

What is the current status of trial NCT03924752?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-02-13. Estimated completion is 2021-03-15.

What conditions does trial NCT03924752 study?

This clinical trial studies the following conditions: Lower Limb Injury.

What interventions are being tested in trial NCT03924752?

The interventions under investigation include: Powered hip exoskeleton (DEVICE).

Who is sponsoring clinical trial NCT03924752?

This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03924752 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Limb Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.